secwatch / observer

8-K filed April 4, 2025, 7:59 PM ET ticker NKTR CIK 0000906709

regulatory confidence high sentiment negative materiality 0.65

Nektar receives Nasdaq delisting notice for bid price below $1.00

NEKTAR THERAPEUTICS

Received Nasdaq notice on April 3, 2025 for non-compliance with minimum bid price rule.
Must regain compliance by September 30, 2025; closing bid price must be at least $1.00 for 10 consecutive days.
If not compliant by deadline, Nasdaq may grant second 180-day grace period subject to conditions.
Company intends to monitor bid price and consider options to regain compliance; no guarantee of success.

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001213900-25-029002
form_type: 8-K
ticker: NKTR
cik: 0000906709
company_name: NEKTAR THERAPEUTICS
filed_at: 2025-04-04T23:59:59+00:00
discovered_at: 2026-05-14T18:02:51.751983+00:00
generated_at: 2026-05-23T22:00:59.042597+00:00
sec_items: ["3.01"]
event_type: regulatory
sentiment: negative
materiality_score: 0.65
calibrated_materiality_score: 0.65
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001213900-25-029002
json_url: https://secwatch.observer/filing/0001213900-25-029002.json
markdown_url: https://secwatch.observer/filing/0001213900-25-029002.md
text_url: https://secwatch.observer/filing/0001213900-25-029002.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/906709/000121390025029002/0001213900-25-029002-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/906709/000121390025029002/ea0237178-8k_nektar.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

JSON Markdown Plain text

Comparable filings

ISPC

iSpecimen flagged for Nasdaq equity shortfall; equity $814K vs $2.5M minimum

iSpecimen Inc. June 1, 2026, 5:00 PM ET regulatory Items 3.01

same SEC item: 3.01 same event type: regulatory similar materiality

Filing page SEC filing

GENC

Gencor receives NYSE American delinquency notice for late Q2 2026 10-Q filing

GENCOR INDUSTRIES INC June 1, 2026, 4:09 PM ET regulatory Items 3.01, 7.01, 9.01

same SEC item: 3.01 same event type: regulatory similar materiality

Filing page SEC filing

NUTR

NusaTrip receives Nasdaq delinquency notice for late 10-K and 10-Q; faces delisting if not compliant by Oct 12, 2026

NUSATRIP Inc June 1, 2026, 7:10 AM ET regulatory Items 3.01, 9.01

same SEC item: 3.01 same event type: regulatory similar materiality

Filing page SEC filing

XXI

Twenty One Capital receives NYSE non-compliance notice; audit committee lacks independence; cure due June 5

Twenty One Capital, Inc. June 1, 2026, 7:05 AM ET regulatory Items 3.01

same SEC item: 3.01 same event type: regulatory similar materiality

Filing page SEC filing

COLA

Columbus Acquisition regains compliance with Nasdaq $50M MVLS rule; delisting risk removed

Columbus Acquisition Corp/Cayman Islands May 29, 2026, 9:56 PM ET regulatory Items 3.01

same SEC item: 3.01 same event type: regulatory similar materiality

Filing page SEC filing

HWH

HWH International receives Nasdaq deficiency notice for equity below $2.5M threshold

HWH International Inc. May 29, 2026, 5:21 PM ET regulatory Items 3.01

same SEC item: 3.01 same event type: regulatory similar materiality

Filing page SEC filing

ATNM

Actinium receives NYSE American non-compliance notice for low stockholders' equity; must submit plan by June 26

Actinium Pharmaceuticals, Inc. May 29, 2026, 5:10 PM ET regulatory Items 3.01, 7.01, 9.01

same SEC item: 3.01 same event type: regulatory similar materiality

Filing page SEC filing

CSAI

Cloudastructure receives Nasdaq delinquency notice for late Q1 10-Q filing

CLOUDASTRUCTURE, INC. May 29, 2026, 5:09 PM ET regulatory Items 3.01, 9.01

same SEC item: 3.01 same event type: regulatory similar materiality

Filing page SEC filing

Source: SEC EDGAR

accession 0001213900-25-029002

view filing index on sec.gov

view primary document

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.